Literature DB >> 1762323

Partial lecithin:cholesterol acyltransferase (LCAT) deficiency in Balkan endemic nephropathy.

N M Pavlović1, Z Varghese, J W Persaud, V Stefanović, S Strahinjić, V Savić, J F Moorehead.   

Abstract

The role of lipid abnormalities has been also implicated in the progression of renal diseases. The search for lipid abnormalities in Balkan endemic nephropathy (BEN) has roused sporadic interest and has not been fully elucidated. This study was performed in 54 healthy subjects from the families affected with BEN (group A), 18 members from non-affected families living in the same location (group B), and 25 control subjects (group C). Lipid profiles and lecithin:cholesterol acyltransferase (LCAT) were determined in each subject. The most striking distinction between the groups was that of the LCAT activity, which was abnormally low in group A (39 +/- 2), significantly different (P less than 0.0001) from that of the other groups. Thirty individuals from group A were those accounting for the low LCAT activity (A1). This group had a significantly lower total cholesterol and free cholesterol than all of the other subjects. The entire group A subjects had a significantly lower percentage of free cholesterol than the other two groups. There was no significant difference in HDL cholesterol between any of the groups, but group A1 had significantly higher HDL than group C (P less than 0.04). What emerges from our study is that a certain proportion of subjects from BEN families have a peculiar form of lipid abnormalities associated with an abnormal LCAT activity. At present we have no explanation for these findings. We believe that these changes may have an important role in the pathogenesis of BEN.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762323

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  6 in total

1.  Limitations and plausibility of the Pliocene lignite hypothesis in explaining the etiology of Balkan endemic nephropathy.

Authors:  S V M Maharaj
Journal:  Int J Occup Environ Health       Date:  2014 Jan-Mar

2.  Comparative (1)H NMR metabolomic urinalysis of people diagnosed with Balkan endemic nephropathy, and healthy subjects, in Romania and Bulgaria: a pilot study.

Authors:  Peter Mantle; Mirela Modalca; Andrew Nicholls; Calin Tatu; Diana Tatu; Draga Toncheva
Journal:  Toxins (Basel)       Date:  2011-07-04       Impact factor: 4.546

Review 3.  Balkan endemic nephropathy-current status and future perspectives.

Authors:  Nikola M Pavlović
Journal:  Clin Kidney J       Date:  2013-06

4.  Organic compounds in water extracts of coal: links to Balkan endemic nephropathy.

Authors:  S V M Maharaj; W H Orem; C A Tatu; H E Lerch; D N Szilagyi
Journal:  Environ Geochem Health       Date:  2013-03-21       Impact factor: 4.609

5.  NGS nominated CELA1, HSPG2, and KCNK5 as candidate genes for predisposition to Balkan endemic nephropathy.

Authors:  D Toncheva; M Mihailova-Hristova; R Vazharova; R Staneva; S Karachanak; P Dimitrov; V Simeonov; S Ivanov; L Balabanski; D Serbezov; M Malinov; V Stefanovic; R Čukuranović; M Polenakovic; L Jankovic-Velickovic; V Djordjevic; T Jevtovic-Stoimenov; D Plaseska-Karanfilska; A Galabov; V Djonov; I Dimova
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

6.  Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology.

Authors:  Rada Staneva; Blaga Rukova; Savina Hadjidekova; Desislava Nesheva; Olga Antonova; Plamen Dimitrov; Valeri Simeonov; Georgi Stamenov; Rade Cukuranovic; Jovana Cukuranovic; Vladislav Stefanovic; Momir Polenakovic; Ivanka Dimova; Ruslan Hlushchuk; Valentin Djonov; Angel Galabov; Draga Toncheva
Journal:  BMC Nephrol       Date:  2013-10-16       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.